Skip to main content
Journal of Medical Case Reports logoLink to Journal of Medical Case Reports
. 2025 Aug 19;19:414. doi: 10.1186/s13256-025-05494-7

Correction: Ibrutinib as treatment for Bing–Neel syndrome reclassified as glioblastoma: a case report

Charlotte Dahl Gravesen 1,, Iman Chanchiri 2, Ida Bruun Kristensen 2, Martin Bang Jensen 3, Frederik Severin Gråe Harbo 4, Rikke Hedegaard Dahlrot 1,5
PMCID: PMC12366369  PMID: 40830506

Correction: Journal of Medical Case Reports (2024) 18: 424 10.1186/s13256-024-04757-z

Following publication of the original article [1], the authors identified an error in the author name of Iman Chanchiri.

The incorrect author name is: Imanl Chanchiri

The correct author name is: Iman Chanchiri

The author group has been updated above and the original article [1] has been corrected.

Footnotes

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Reference

  • 1.Gravesen CD, Chanchiri I, Kristensen IB, et al. Ibrutinib as treatment for Bing–Neel syndrome reclassified as glioblastoma: a case report. J Med Case Rep. 2024;18:424. 10.1186/s13256-024-04757-z. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Journal of Medical Case Reports are provided here courtesy of BMC

RESOURCES